DID YOU KNOW? DTIC has over 3.5 million final reports on DoD funded research, development, test, and evaluation activities available to our registered users. Click
HERE to register or log in.
Accession Number:
ADA621091
Title:
Cell of Origin and Cancer Stem Cell Phenotype in Medulloblastomas
Descriptive Note:
Annual rept. 1 Jul 2014-30 Jun 2015
Corporate Author:
JACKSON LAB BAR HARBOR ME
Report Date:
2015-07-01
Pagination or Media Count:
10.0
Abstract:
The goal of this project is to test our hypothesis that cellular context in which tumors initiate may have a dominant role over some oncogene function in determining molecular phenotypes. To test this hypothesis, we proposed to transform neural stem cells NSCs and neural progenitor cells NPCs by expressing an activated form of Notch1 N1ICD or oncogenic PIK3CA PIK3CA in the developing mouse cerebellum, using cell type- specific Cre drivers En2-Cre for NSCs and Atoh1-creER for NPCs. During this funding period, we were successful in intercrossing N1ICD, En2-Cre, Atoh1-cre, and p53 strains to generate N1ICDEn2-crep53-- and N1ICDAtoh1-CreERp53-- mice. We are currently aging these mice to collect medulloblastomas for molecular analyses. For PIK3CA-induced models, we first analyzed the effect of PIK3CA expression in different cellular compartments in the developing brain since this is a new model and the effects of oncogenic PIK3CA expression in the developing brain is unknown. Our analyses showed that our PIK3CA transgenic model is functional and that oncogenic PIK3CA expression in the developing brain affects proliferation and differentiation. We are intercrossing PIK3CA mice with Atoh1-cre, En2-cre, and p53-- mice to generate PIK3CAAtoh1-CreERp53-- and PIK3CAAtoh1-CreERp53-- mice to generate spontaneous medulloblastomas.
Distribution Statement:
APPROVED FOR PUBLIC RELEASE
